In a clinical trial of 2539 participants, those using tirzepatide over 72 weeks experienced weight loss, with averages of 15% for the 5 mg dose, 20% for the 10 mg dose, and 21% for the 15 mg dose, compared with a 3% reduction in the placebo group
Track your reconstitution date carefully and discard solutions exceeding recommended storage times
Child-Pugh scores before and after oral L-carnitine administration differed significantly, whereas liver reserve function, nutritional status, and muscle index did not change significantly
and certain medical conditions (ie, pancreatitis, type 1 diabetes, thyroid cancer, and gastroparesis) based on contraindications, warnings, and limited use information for semaglutide and tirzepatide (eTable 2 in Supplement 1)
Interleukin 6 receptor is not directly involved in regulation of body weight in diet-induced obesity with and without physical exercise
These conditions increase the risk of eye damage, including concerns related to Mounjaro vision loss lawsuits